Cancer and nanotechnology: A mini review

Ahmad Gholami; Fatemeh Mehrabi

Ahmad Gholami
Fatemeh Mehrabi

Keywords: Nanoparticle, theranostics, imaging

Abstract

Cancer is a complex disease that is challenging globally. There are different types of this disease and many people suffer from it. According to global data, in 2020, about 19.3 million new cases and about 10 million deaths have been estimated. Therefore, timely diagnosis and appropriate treatment for any type of cancer is very important. Therapies include chemotherapy and radiotherapy; etc. existing treatments currently have many side effects. Therefore, scientists are looking for new ways to reduce these side effects. In recent years, nanotechnology has received much attention in the diagnosis, imaging and treatment of this disease. Nanoscience, especially nanoparticles in the field of drug delivery, imaging and treatment has helped a lot in the field of cancer, and in recent years, nanotranoscience has applied this science. nanotheranostics is a combination of treatment and diagnosis that allows doctors to make progress in treatment and Provide. appropriate dosing and timely intervention and provide chemotherapy for cancer by increasing efficacy and reducing toxicity.

Downloads

Download data is not yet available.

Author Biography

Ahmad Gholami

Dear Dr. Gholmai

Thank you very much for Contribiutation.

We are glad to know about your willingness to contribute and first request you to provide us your CV and tentative title of a thematic proposal that you wish to work on for editorial consideration.
Looking forward to hearing from you soon.
With best wishes

Seyyed Mojtaba Mousavi
Editor-in-Chief

The username can contain only lower-case alphanumeric characters, underscores, and hyphens, and must begin and end with an alphanumeric character.

References

1. Zhang P, Hu C, Ran W, Meng J, Yin Q, Li Y. Recent progress in light-triggered nanotheranostics for cancer treatment. Theranostics. 2016;6(7):948.
2. Xu T, Zhang N, Nichols HL, Shi D, Wen X. Modification of nanostructured materials for biomedical applications. Materials Science and Engineering: C. 2007;27(3):579-94.
3. Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Current Opinion in Solid State and Materials Science. 2002;6(4):319-27.
4. Danhier F, Ansorena E, Silva JM, Coco R, Le Breton A, Préat V. PLGA-based nanoparticles: an overview of biomedical applications. Journal of controlled release. 2012;161(2):505-22.
5. Omrani MM, Ansari M, Kiaie N. Therapeutic effect of stem cells and nano-biomaterials on Alzheimer's disease. Biointerface Research in Applied Chemistry. 2016;6(6).
6. Omidifar N, Nili-Ahmadabadi A, Nakhostin-Ansari A, Lankarani KB, Moghadami M, Mousavi SM, et al. The modulatory potential of herbal antioxidants against oxidative stress and heavy metal pollution: plants against environmental oxidative stress. Environmental Science and Pollution Research. 2021:1-11.
7. Lü J-M, Wang X, Marin-Muller C, Wang H, Lin PH, Yao Q, et al. Current advances in research and clinical applications of PLGA-based nanotechnology. Expert review of molecular diagnostics. 2009;9(4):325-41.
8. Rao JP, Geckeler KE. Polymer nanoparticles: preparation techniques and size-control parameters. Progress in polymer science. 2011;36(7):887-913.
9. Hu C-MJ, Aryal S, Zhang L. Nanoparticle-assisted combination therapies for effective cancer treatment. Therapeutic delivery. 2010;1(2):323-34.
10. Labhasetwar V, Song C, Levy RJ. Nanoparticle drug delivery system for restenosis. Advanced Drug Delivery Reviews. 1997;24(1):63-85.
11. Lankalapalli S, Routhu KC, Ojha S, Tenneti VVK. Nanoparticulate Drug Delivery Systems: Promising Approaches For Drug Delivery. Journal of Drug Delivery and Therapeutics. 2014:72-85.
12. Park JW. Liposome-based drug delivery in breast cancer treatment. Breast Cancer Research. 2002;4(3):1-5.
13. Wu X, Liu H, Liu J, Haley KN, Treadway JA, Larson JP, et al. Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots. Nature biotechnology. 2003;21(1):41-6.
14. Ahmadi S, Fazilati M, Nazem H, Mousavi SM. Green synthesis of magnetic nanoparticles using Satureja hortensis essential oil toward superior antibacterial/fungal and anticancer performance. BioMed Research International. 2021;2021.
15. Kamaly N, Yameen B, Wu J, Farokhzad OC. Degradable controlled-release polymers and polymeric nanoparticles: mechanisms of controlling drug release. Chemical reviews. 2016;116(4):2602-63.
16. Song X, Chen Q, Liu Z. Recent advances in the development of organic photothermal nano-agents. Nano Research. 2015;8(2):340-54.
17. Chen Y, Li H, Deng Y, Sun H, Ke X, Ci T. Near-infrared light triggered drug delivery system for higher efficacy of combined chemo-photothermal treatment. Acta biomaterialia. 2017;51:374-92.
18. Silva CO, Pinho JO, Lopes JM, Almeida AJ, Gaspar MM, Reis C. Current trends in cancer nanotheranostics: metallic, polymeric, and lipid-based systems. Pharmaceutics. 2019;11(1):22.
19. Mousavi SM, Low FW, Hashemi SA, Samsudin NA, Shakeri M, Yusoff Y, et al. Development of hydrophobic reduced graphene oxide as a new efficient approach for photochemotherapy. RSC Advances. 2020;10(22):12851-63.
20. Cartwright AN, Nicolau DV, Fixler D, editors. Nanoscale Imaging, Sensing, and Actuation for Biomedical Applications XV2018: SPIE.
21. Oliveira Pinho J, Matias M, Gaspar MM. Emergent nanotechnological strategies for systemic chemotherapy against melanoma. Nanomaterials. 2019;9(10):1455.
22. Perrie Y, Ramsay E. Nanomedicines: exploring the past, present and future. Drug Discovery World. 2017;18(Fall):17-22.
23. Dykman LA, Khlebtsov NG. Multifunctional gold-based nanocomposites for theranostics. Biomaterials. 2016;108:13-34.
24. Avval ZM, Malekpour L, Raeisi F, Babapoor A, Mousavi SM, Hashemi SA, et al. Introduction of magnetic and supermagnetic nanoparticles in new approach of targeting drug delivery and cancer therapy application. Drug metabolism reviews. 2020;52(1):157-84.
25. Lammers T, Kiessling F, Hennink WE, Storm G. Nanotheranostics and image-guided drug delivery: current concepts and future directions. Molecular pharmaceutics. 2010;7(6):1899-912.
26. Kostevsek N, Locatelli E, Garrovo C, Arena F, Monaco I, Nikolov IP, et al. The one-step synthesis and surface functionalization of dumbbell-like gold–iron oxide nanoparticles: a chitosan-based nanotheranostic system. Chemical Communications. 2016;52(2):378-81.
27. Moteshafi H, Mousavi S, Shojaosadati S. The possible mechanisms involved in nanoparticles biosynthesis. Journal of Industrial and Engineering Chemistry. 2012;18(6):2046-50.
28. Ahmadi S, Fazilati M, Mousavi SM, Nazem H. Anti-bacterial/fungal and anti-cancer performance of green synthesized Ag nanoparticles using summer savory extract. Journal of Experimental Nanoscience. 2020;15(1):363-80.
29. Willerding L, Limmer S, Hossann M, Zengerle A, Wachholz K, Ten Hagen TL, et al. Method of hyperthermia and tumor size influence effectiveness of doxorubicin release from thermosensitive liposomes in experimental tumors. Journal of Controlled Release. 2016;222:47-55.
30. Silva CO, Petersen SB, Reis CP, Rijo P, Molpeceres J, Fernandes AS, et al. EGF functionalized polymer-coated gold nanoparticles promote EGF photostability and EGFR internalization for photothermal therapy. PLoS One. 2016;11(10):e0165419.
31. Dubey RD, Klippstein R, Wang JT-W, Hodgins N, Mei K-C, Sosabowski J, et al. Novel hyaluronic acid conjugates for dual nuclear imaging and therapy in CD44-expressing tumors in mice in vivo. Nanotheranostics. 2017;1(1):59.
32. Oliveira Silva C, Petersen SB, Pinto Reis C, Rijo P, Molpeceres J, Vorum H, et al. Lysozyme photochemistry as a function of temperature. the protective effect of nanoparticles on lysozyme photostability. PLoS One. 2015;10(12):e0144454.
33. Silva CO, Molpeceres J, Batanero B, Fernandes AS, Saraiva N, Costa JG, et al. Functionalized diterpene parvifloron D-loaded hybrid nanoparticles for targeted delivery in melanoma therapy. Therapeutic delivery. 2016;7(8):521-44.
34. Mousavi SM, Zarei M, Hashemi SA, Ramakrishna S, Chiang W-H, Lai CW, et al. Gold nanostars-diagnosis, bioimaging and biomedical applications. Drug metabolism reviews. 2020;52(2):299-318.
35. Mousavi SM, Hashemi SA, Behbudi G, Mazraedoost S, Omidifar N, Gholami A, et al. A Review on Health Benefits of Malva sylvestris L. Nutritional Compounds for Metabolites, Antioxidants, and Anti-Inflammatory, Anticancer, and Antimicrobial Applications. Evidence-Based Complementary and Alternative Medicine. 2021;2021.
36. Zhao Z, Lou S, Hu Y, Zhu J, Zhang C. A nano-in-nano polymer–dendrimer nanoparticle-based nanosystem for controlled multidrug delivery. Molecular pharmaceutics. 2017;14(8):2697-710.
37. Lou S, Zhao Z, Dezort M, Lohneis T, Zhang C. Multifunctional nanosystem for targeted and controlled delivery of multiple chemotherapeutic agents for the treatment of drug-resistant breast cancer. ACS omega. 2018;3(8):9210-9.
38. Tang H, Guo Y, Peng L, Fang H, Wang Z, Zheng Y, et al. In vivo targeted, responsive, and synergistic cancer nanotheranostics by magnetic resonance imaging-guided synergistic high-intensity focused ultrasound ablation and chemotherapy. ACS applied materials & interfaces. 2018;10(18):15428-41.
39. Perlman O, Weitz IS, Sivan SS, Abu-Khalla H, Benguigui M, Shaked Y, et al. Copper oxide loaded PLGA nanospheres: towards a multifunctional nanoscale platform for ultrasound-based imaging and therapy. Nanotechnology. 2018;29(18):185102.
40. Maeda H. Polymer therapeutics and the EPR effect. Journal of drug targeting. 2017;25(9-10):781-5.
41. Nabil G, Bhise K, Sau S, Atef M, El-Banna HA, Iyer AK. Nano-engineered delivery systems for cancer imaging and therapy: Recent advances, future direction and patent evaluation. Drug Discovery Today. 2019;24(2):462-91.
42. Jain RK, Stylianopoulos T. Delivering nanomedicine to solid tumors. Nature reviews Clinical oncology. 2010;7(11):653-64.
43. Holback H, Yeo Y. Intratumoral drug delivery with nanoparticulate carriers. Pharmaceutical research. 2011;28(8):1819-30.
44. Jain RK, Martin JD, Stylianopoulos T. The role of mechanical forces in tumor growth and therapy. Annual review of biomedical engineering. 2014;16:321-46.
45. Kim KY. Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine: Nanotechnology, Biology and Medicine. 2007;3(2):103-10.
46. Liu D, He C, Wang AZ, Lin W. Application of liposomal technologies for delivery of platinum analogs in oncology. International journal of nanomedicine. 2013;8:3309.
47. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, Szewczyk A. A two-stage poly (ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Molecular therapy. 2005;11(6):990-5.
48. Tan S, Gan C, Li R, Ye Y, Zhang S, Wu X, et al. A novel chemosynthetic peptide with β-sheet motif efficiently kills Klebsiella pneumoniae in a mouse model. International journal of nanomedicine. 2015;10:1045.
49. Kim J, Dadsetan M, Ameenuddin S, Windebank AJ, Yaszemski MJ, Lu L. In vivo biodegradation and biocompatibility of PEG/sebacic acid‐based hydrogels using a cage implant system. Journal of biomedical materials research Part A. 2010;95(1):191-7.
50. Nicolete R, dos Santos DF, Faccioli LH. The uptake of PLGA micro or nanoparticles by macrophages provokes distinct in vitro inflammatory response. International immunopharmacology. 2011;11(10):1557-63.
51. Ceonzo K, Gaynor A, Shaffer L, Kojima K, Vacanti CA, Stahl GL. Polyglycolic acid-induced inflammation: role of hydrolysis and resulting complement activation. Tissue engineering. 2006;12(2):301-8.
52. Chen H-T, Neerman MF, Parrish AR, Simanek EE. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery. Journal of the American Chemical Society. 2004;126(32):10044-8.
53. Ma Y, Mou Q, Wang D, Zhu X, Yan D. Dendritic polymers for theranostics. Theranostics. 2016;6(7):930.
54. Jain K, Kesharwani P, Gupta U, Jain N. Dendrimer toxicity: Let's meet the challenge. International journal of pharmaceutics. 2010;394(1-2):122-42.
55. Madaan K, Kumar S, Poonia N, Lather V, Pandita D. Dendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issues. Journal of pharmacy & bioallied sciences. 2014;6(3):139.
56. Kesharwani P, Jain K, Jain NK. Dendrimer as nanocarrier for drug delivery. Progress in Polymer Science. 2014;39(2):268-307.
57. Gu Y, Zhong Y, Meng F, Cheng R, Deng C, Zhong Z. Acetal-linked paclitaxel prodrug micellar nanoparticles as a versatile and potent platform for cancer therapy. Biomacromolecules. 2013;14(8):2772-80.
58. Yang Y, Shao Q, Deng R, Wang C, Teng X, Cheng K, et al. In vitro and in vivo uncaging and bioluminescence imaging by using photocaged upconversion nanoparticles. Angewandte Chemie. 2012;124(13):3179-83.